The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Reginaldo A. Saraceno
Advertisement
Reginaldo A. Saraceno is director, Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals.
Articles by Reginaldo A. Saraceno
Advertisement
Latest Updated Articles
Advertisement
Advertisement